Found: 62
Select item for more details and to access through your institution.
First-dose and steady-state pharmacokinetics of orally administered crizotinib in children with solid tumors: a report on ADVL0912 from the Children's Oncology Group Phase 1/Pilot Consortium.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Congenital Infantile Fibrosarcoma Involving Pelvic Wall and Thigh Soft Tissues and Placenta, Presenting with Coagulopathy.
- Published in:
- Pediatric & Developmental Pathology, 2022, v. 25, n. 6, p. 656, doi. 10.1177/10935266221114017
- By:
- Publication type:
- Article
A phase 1 trial of temsirolimus and intensive re-induction chemotherapy for 2nd or greater relapse of acute lymphoblastic leukaemia: a Children's Oncology Group study ( ADVL1114).
- Published in:
- British Journal of Haematology, 2017, v. 177, n. 3, p. 467, doi. 10.1111/bjh.14569
- By:
- Publication type:
- Article
New paradigms for therapy for osteosarcoma.
- Published in:
- Current Oncology Reports, 2005, v. 7, n. 6, p. 410, doi. 10.1007/s11912-005-0005-1
- By:
- Publication type:
- Article
Toll-like receptor-7 agonist administered subcutaneously in a prolonged dosing schedule in heavily pretreated recurrent breast, ovarian, and cervix cancers.
- Published in:
- Cancer Immunology, Immunotherapy, 2010, v. 59, n. 12, p. 1877, doi. 10.1007/s00262-010-0914-1
- By:
- Publication type:
- Article
3488 A comparison between the Rolling 6 and 3+3 dose escalation study designs for phase 1 clinical trials.
- Published in:
- 2019
- By:
- Publication type:
- Abstract
Prognostic Factors for Development of Subsequent Metastases in Localized Osteosarcoma: A Systematic Review and Identification of Literature Gaps.
- Published in:
- Sarcoma, 2020, p. 1, doi. 10.1155/2020/7431549
- By:
- Publication type:
- Article
Intercontinental collaboration in clinical trials for children and adolescents with cancer—A systematic review by ACCELERATE.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 23, p. 8462, doi. 10.1002/cam4.4356
- By:
- Publication type:
- Article
Metabolic response as assessed by <sup>18</sup>F‐fluorodeoxyglucose positron emission tomography‐computed tomography does not predict outcome in patients with intermediate‐ or high‐risk rhabdomyosarcoma: A report from the Children's Oncology Group Soft Tissue Sarcoma Committee
- Published in:
- Cancer Medicine, 2021, v. 10, n. 3, p. 857, doi. 10.1002/cam4.3667
- By:
- Publication type:
- Article
Phase 1 trial of olaratumab monotherapy and in combination with chemotherapy in pediatric patients with relapsed/refractory solid and central nervous system tumors.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 3, p. 843, doi. 10.1002/cam4.3658
- By:
- Publication type:
- Article
Chemotherapy Options for Poor Responders to Neoadjuvant Chemotherapy for Orbital Granulocytic Sarcoma.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Successful management of an arteriovenous malformation with trametinib in a patient with capillary‐malformation arteriovenous malformation syndrome and cardiac compromise.
- Published in:
- Pediatric Dermatology, 2022, v. 39, n. 2, p. 316, doi. 10.1111/pde.14912
- By:
- Publication type:
- Article
Toxicity and pharmacokinetics of actinomycin-D and vincristine in children and adolescents: Children's Oncology Group Study ADVL06B1.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2021, v. 88, n. 2, p. 359, doi. 10.1007/s00280-021-04295-1
- By:
- Publication type:
- Article
Safety, tolerability and pharmacokinetics of crizotinib in combination with cytotoxic chemotherapy for pediatric patients with refractory solid tumors or anaplastic large cell lymphoma (ALCL): a Children's Oncology Group phase 1 consortium study (ADVL1212)
- Published in:
- Cancer Chemotherapy & Pharmacology, 2020, v. 86, n. 6, p. 829, doi. 10.1007/s00280-020-04171-4
- By:
- Publication type:
- Article
Wee1 kinase inhibitor adavosertib with radiation in newly diagnosed diffuse intrinsic pontine glioma: A Children's Oncology Group phase I consortium study.
- Published in:
- Neuro-Oncology Advances, 2022, v. 4, n. 1, p. 1, doi. 10.1093/noajnl/vdac073
- By:
- Publication type:
- Article
A phase 1/2 study of pepinemab in children, adolescents, or young adults with recurrent or refractory solid tumors: A children's oncology group consortium report (ADVL1614).
- Published in:
- Pediatric Blood & Cancer, 2024, v. 71, n. 6, p. 1, doi. 10.1002/pbc.30938
- By:
- Publication type:
- Article
A phase 1 trial utilizing a pharmacokinetic endpoint to determine the optimal dose of ramucirumab in children and adolescents with relapsed or refractory solid tumors, including central nervous system tumors.
- Published in:
- Pediatric Blood & Cancer, 2024, v. 71, n. 3, p. 1, doi. 10.1002/pbc.30817
- By:
- Publication type:
- Article
Feasibility of pevonedistat combined with azacitidine, fludarabine, cytarabine in pediatric relapsed/refractory AML: Results from COG ADVL1712.
- Published in:
- Pediatric Blood & Cancer, 2023, v. 70, n. 12, p. 1, doi. 10.1002/pbc.30672
- By:
- Publication type:
- Article
Palbociclib in combination with chemotherapy in pediatric and young adult patients with relapsed/refractory acute lymphoblastic leukemia and lymphoma: A Children's Oncology Group study (AINV18P1).
- Published in:
- Pediatric Blood & Cancer, 2023, v. 70, n. 11, p. 1, doi. 10.1002/pbc.30609
- By:
- Publication type:
- Article
Children's Oncology Group's 2023 blueprint for research: Developmental therapeutics.
- Published in:
- Pediatric Blood & Cancer, 2023, v. 70, p. 1, doi. 10.1002/pbc.30563
- By:
- Publication type:
- Article
Children's Oncology Group's 2023 blueprint for research: Developmental therapeutics.
- Published in:
- Pediatric Blood & Cancer, 2023, v. 70, p. 1, doi. 10.1002/pbc.30563
- By:
- Publication type:
- Article
A pilot study evaluating the use of sirolimus in children and young adults with desmoid‐type fibromatosis.
- Published in:
- Pediatric Blood & Cancer, 2023, v. 70, n. 9, p. 1, doi. 10.1002/pbc.30466
- By:
- Publication type:
- Article
Rhabdomyosarcoma with isolated lung metastases: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.
- Published in:
- Pediatric Blood & Cancer, 2023, v. 70, n. 6, p. 1, doi. 10.1002/pbc.30293
- By:
- Publication type:
- Article
A phase 1 study of prexasertib (LY2606368), a CHK1/2 inhibitor, in pediatric patients with recurrent or refractory solid tumors, including CNS tumors: A report from the Children's Oncology Group Pediatric Early Phase Clinical Trials Network (ADVL1515).
- Published in:
- Pediatric Blood & Cancer, 2021, v. 68, n. 9, p. 1, doi. 10.1002/pbc.29065
- By:
- Publication type:
- Article
A phase 1 study of entinostat in children and adolescents with recurrent or refractory solid tumors, including CNS tumors: Trial ADVL1513, Pediatric Early Phase‐Clinical Trial Network (PEP‐CTN).
- Published in:
- Pediatric Blood & Cancer, 2021, v. 68, n. 4, p. 1, doi. 10.1002/pbc.28892
- By:
- Publication type:
- Article
Safety and efficacy of gamma-secretase inhibitor nirogacestat (PF-03084014) in desmoid tumor: Report of four pediatric/young adult cases.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Treatment of generalized infantile myofibromatosis with sorafenib and imatinib: A case report.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Phase 1/2 trial of talazoparib in combination with temozolomide in children and adolescents with refractory/recurrent solid tumors including Ewing sarcoma: A Children's Oncology Group Phase 1 Consortium study (ADVL1411).
- Published in:
- 2020
- By:
- Publication type:
- journal article
A phase 1 study of cabozantinib in children and adolescents with recurrent or refractory solid tumors, including CNS tumors: Trial ADVL1211, a report from the Children's Oncology Group.
- Published in:
- 2018
- By:
- Publication type:
- journal article
A phase 1 study of eribulin mesylate (E7389), a novel microtubule-targeting chemotherapeutic agent, in children with refractory or recurrent solid tumors: A Children's Oncology Group Phase 1 Consortium study (ADVL1314).
- Published in:
- 2018
- By:
- Publication type:
- journal article
Phase 1 trial of ontuxizumab (MORAb-004) in children with relapsed or refractory solid tumors: A report from the Children's Oncology Group Phase 1 Pilot Consortium (ADVL1213).
- Published in:
- 2018
- By:
- Publication type:
- journal article
Histology, fusion status, and outcome in metastatic rhabdomyosarcoma: A report from the Children's Oncology Group.
- Published in:
- 2017
- By:
- Publication type:
- journal article
A phase 1 study of the c-Met inhibitor, tivantinib (ARQ197) in children with relapsed or refractory solid tumors: A Children's Oncology Group study phase 1 and pilot consortium trial (ADVL1111).
- Published in:
- 2017
- By:
- Publication type:
- journal article
Patterns of chemotherapy-induced toxicities and outcome in children and adolescents with metastatic rhabdomyosarcoma: A report from the Children's Oncology Group.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Phase 2 trial of sorafenib in children and young adults with refractory solid tumors: A report from the Children's Oncology Group.
- Published in:
- 2015
- By:
- Publication type:
- journal article
A phase 1 dosing study of ruxolitinib in children with relapsed or refractory solid tumors, leukemias, or myeloproliferative neoplasms: A Children's Oncology Group phase 1 consortium study (ADVL1011).
- Published in:
- Pediatric Blood & Cancer, 2015, v. 62, n. 10, p. 1717, doi. 10.1002/pbc.25575
- By:
- Publication type:
- Article
A phase I trial and viral clearance study of reovirus (Reolysin) in children with relapsed or refractory extra-cranial solid tumors: A Children's Oncology Group Phase I Consortium report.
- Published in:
- Pediatric Blood & Cancer, 2015, v. 62, n. 5, p. 751, doi. 10.1002/pbc.25464
- By:
- Publication type:
- Article
Phase I trial of Seneca Valley Virus (NTX-010) in children with relapsed/refractory solid tumors: A report of the Children's Oncology Group.
- Published in:
- Pediatric Blood & Cancer, 2015, v. 62, n. 5, p. 743, doi. 10.1002/pbc.25269
- By:
- Publication type:
- Article
Phase II study of cixutumumab in combination with temsirolimus in pediatric patients and young adults with recurrent or refractory sarcoma: A report from the children's oncology group.
- Published in:
- Pediatric Blood & Cancer, 2015, v. 62, n. 3, p. 440, doi. 10.1002/pbc.25334
- By:
- Publication type:
- Article
Growth plate abnormalities in pediatric cancer patients undergoing phase 1 anti-angiogenic therapy: A report from the children's oncology group phase I consortium.
- Published in:
- Pediatric Blood & Cancer, 2015, v. 62, n. 1, p. 45, doi. 10.1002/pbc.25229
- By:
- Publication type:
- Article
A phase I trial of MK-2206 in children with refractory malignancies: A Children's Oncology Group study.
- Published in:
- Pediatric Blood & Cancer, 2014, v. 61, n. 7, p. 1246, doi. 10.1002/pbc.25023
- By:
- Publication type:
- Article
Phase 1 trial of temsirolimus in combination with irinotecan and temozolomide in children, adolescents and young adults with relapsed or refractory solid tumors: A children's oncology group study.
- Published in:
- Pediatric Blood & Cancer, 2014, v. 61, n. 5, p. 833, doi. 10.1002/pbc.24874
- By:
- Publication type:
- Article
Phase 2 trial of cixutumumab in children, adolescents, and young adults with refractory solid tumors: A report from the Children's Oncology Group.
- Published in:
- Pediatric Blood & Cancer, 2014, v. 61, n. 3, p. 452, doi. 10.1002/pbc.24605
- By:
- Publication type:
- Article
A therapeutic trial of decitabine and vorinostat in combination with chemotherapy for relapsed/refractory acute lymphoblastic leukemia.
- Published in:
- American Journal of Hematology, 2014, v. 89, n. 9, p. 889, doi. 10.1002/ajh.23778
- By:
- Publication type:
- Article
Prolonged subcutaneous administration of 852A, a novel systemic toll-like receptor 7 agonist, to activate innate immune responses in patients with advanced hematologic malignancies.
- Published in:
- American Journal of Hematology, 2012, v. 87, n. 10, p. 953, doi. 10.1002/ajh.23280
- By:
- Publication type:
- Article
Associations of Socioeconomic Status, Public vs Private Insurance, and Race/Ethnicity With Metastatic Sarcoma at Diagnosis.
- Published in:
- JAMA Network Open, 2020, v. 3, n. 8, p. e2011087, doi. 10.1001/jamanetworkopen.2020.11087
- By:
- Publication type:
- Article
The addition of cixutumumab or temozolomide to intensive multiagent chemotherapy is feasible but does not improve outcome for patients with metastatic rhabdomyosarcoma: A report from the Children's Oncology Group.
- Published in:
- 2019
- By:
- Publication type:
- journal article
A study of axitinib, a VEGF receptor tyrosine kinase inhibitor, in children and adolescents with recurrent or refractory solid tumors: A Children's Oncology Group phase 1 and pilot consortium trial (ADVL1315).
- Published in:
- 2018
- By:
- Publication type:
- journal article
Historical time to disease progression and progression-free survival in patients with recurrent/refractory neuroblastoma treated in the modern era on Children's Oncology Group early-phase trials.
- Published in:
- 2017
- By:
- Publication type:
- journal article
A pediatric phase 1 trial of vorinostat and temozolomide in relapsed or refractory primary brain or spinal cord tumors: A children's oncology group phase 1 consortium study.
- Published in:
- Pediatric Blood & Cancer, 2013, v. 60, n. 9, p. 1452, doi. 10.1002/pbc.24541
- By:
- Publication type:
- Article